Position in GMAB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$827,168
-$19,678 QoQ
Shares Held
30,830
+12.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 11%
Shared 89%
None 0%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VIRTUS ADVISERS, LLC holds $6,375,075 across 18 Biotechnology names. GMAB ranks #2 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
42,974 | $956,600 | |
| 2 | GMAB |
Genmab A/S
This page
|
30,830 | $827,168 | |
| 3 | INVA |
Innoviva, Inc.
|
26,946 | $627,841 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
25,800 | $561,408 | |
| 5 | EXEL |
Exelixis, Inc.
|
13,000 | $557,570 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,805 | $552,073 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
15,850 | $439,045 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
15,399 | $431,325 |
All Filings in GMAB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $827,168 | 30,830 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $846,846 | 27,495 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $843,271 | 27,495 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $568,046 | 27,495 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||